Innospec stock hits 52-week low at $80.01

Published 31/07/2025, 14:32
Innospec stock hits 52-week low at $80.01

Innospec Inc (NASDAQ:IOSP)’s stock reached a new 52-week low at $80.01, marking a significant downturn for the specialty chemicals company. According to InvestingPro data, the company maintains strong fundamentals with a healthy current ratio of 2.73 and more cash than debt on its balance sheet. Over the past year, Innospec has experienced a substantial decline, with its stock price dropping by 35.64%. Despite these challenges, the company has maintained its dividend payments for 14 consecutive years, with a current yield of 2.08%. This decrease reflects broader challenges within the sector, as well as company-specific issues that have impacted investor confidence. The new low highlights ongoing volatility and pressures in the market, prompting analysts and investors to closely monitor Innospec’s financial health and strategic responses to these challenges. Notably, analysts maintain a positive outlook with a $115 price target. For deeper insights into Innospec’s valuation and 10+ additional ProTips, check out the comprehensive research report available on InvestingPro.

In other recent news, Innospec Inc. announced its first-quarter 2025 earnings, which showed a decline in revenue and a slight miss on earnings per share (EPS) expectations. The company reported revenue of $440.8 million, falling short of the projected $462 million. EPS was recorded at $1.42, slightly below the anticipated $1.44. Additionally, Innospec held its annual shareholder meeting, where three Class III directors were elected, and executive compensation was approved. The elected directors include David F. Landless, Lawrence J. Padfield, and Patrick S. Williams, each receiving significant support from shareholders. The meeting results were documented in the company’s latest 8-K filing with the Securities and Exchange Commission. These developments come amid investor concerns about the company’s recent performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.